OS Therapies Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OS Therapies Inc. on August 15, 2025. The report addresses a corporate governance amendment approved by the Board of Directors on the same date. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Grasonville, Maryland.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change to the Company's Bylaws and does not contain financial performance data.
Material Changes
The Board of Directors approved an amendment to Section 3.10 of Article III of the Company's Amended and Restated Bylaws. The key change is as follows:
- Quorum Requirement: The quorum for the transaction of business at stockholder meetings has been changed to one-third of the voting power of the outstanding shares entitled to vote, present in person or by proxy.
- Class Voting: For matters requiring a separate vote by class, the holders of one-third of the voting power of that specific class constitute a quorum.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The document is limited to the procedural amendment of the Bylaws.
Key Facts for Investor Verification
- Verify the effective date of the Bylaw amendment (August 15, 2025).
- Confirm the new quorum threshold is set at one-third of voting power.
- Review Exhibit 3.1 attached to the filing for the full legal text of Amendment No. 1 to the Amended and Restated Bylaws.
- Note that this filing does not disclose any financial results or operational updates.